BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated β-catenin signaling.
about
HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastomaClipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.Genomic and functional characterization of coleopteran insect-specific α-amylase inhibitor gene from Amaranthus species.MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions.
P2860
BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated β-catenin signaling.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
BASI, a potent small molecular ...... -mediated β-catenin signaling.
@en
type
label
BASI, a potent small molecular ...... -mediated β-catenin signaling.
@en
prefLabel
BASI, a potent small molecular ...... -mediated β-catenin signaling.
@en
P2093
P2860
P356
P1476
BASI, a potent small molecular ...... A-mediated β-catenin signaling
@en
P2093
Chun-Sheng Kang
Jian-Ning Zhang
Jun-Xia Zhang
Kai-Liang Zhang
Lu-Yue Chen
Xiao-Min Qian
Zhen-Dong Shi
P2860
P304
P356
10.1111/CNS.12278
P577
2014-05-09T00:00:00Z